Investigation of the nonmotor symptoms in patients with STN-DBS therapy in comparison with those without STN-DBS.

Nonmotor symptoms Parkinson’s disease Quality of life STN-DBS

Journal

Journal of neural transmission (Vienna, Austria : 1996)

ISSN: 1435-1463

Titre abrégé: J Neural Transm (Vienna)

Pays: Austria

ID NLM: 9702341

Informations de publication

Date de publication:
30 Apr 2024

Historique:

received: 27 01 2024

accepted: 04 04 2024

medline: 30 4 2024

pubmed: 30 4 2024

entrez: 29 4 2024

Statut: aheadofprint

Résumé

The impact of STN-DBS on NMS remains rather as an underestimated topic. Besides, the significance of NMSs in QOL indexes of PD subjects with STN-DBS is unknown. We primarily aimed to evaluate the NMSs and their significance in QOL indexes in PD subjects comparatively with and without STN-DBS therapy. We enrolled all consecutive PD subjects with and without STN-DBS who applied to our movement disorders outpatient clinics between January/2023 and September/2023. We performed comprehensive assessments of the motor and nonmotor features including the clinical scales of Movement Disorder Society-sponsored revision of the MDS-UPDRS, NMSS, HAM-A, HAM-D, and the PDQ-39. Overall, 48 PD subjects with STN-DBS and 161 without STN-DBS treatment were included. The comparative analyses revealed that the sub-scores of the MDS-UPDRS-2, -3 and -4 were higher in the STN-DBS group. However, the MDS-UDPRS-1 and the total scores of the NMSS were similar between groups. Among eight subitems of the NMSS, only, the sub scores of the mood/cognition and the gastrointestinal tract differed. Remarkably, the significant correlations between the scores of the QOL and the NMSS scores in the STN-DBS (-) group, did not persist within the STN-DBS group. Remarkably, the correlations between the NMSS and PQQ-39 disappeared for most of the sub scores within the STN-DBS group. We found indirect evidence regarding the benefit of STN-DBS therapy on NMSs in our cross-sectional study. Besides, we found weaker impact of NMSs in QOL indexes in PD subjects with STN-DBS therapy.

Identifiants

DOI: 10.1007/s00702-024-02778-y PMID: 38684577

pubmed: 38684577

doi: 10.1007/s00702-024-02778-y

pii: 10.1007/s00702-024-02778-y

doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

Informations de copyright

Références

Amara AW et al (2011) The effects of deep brain stimulation on sleep in Parkinson’s disease. Ther Adv Neurol Disord 4(1):15–24

doi: 10.1177/1756285610392446 pubmed: 21339905 pmcid: 3036959

Arnulf I et al (2000) Improvement of sleep architecture in PD with subthalamic nucleus stimulation. Neurology 55(11):1732–1734

doi: 10.1212/WNL.55.11.1732 pubmed: 11113233

Büttner C et al (2019) The evolution of quality of life after subthalamic stimulation for Parkinson’s disease: a meta-analysis. Mov Disord Clin Pract 6(7):521–530

doi: 10.1002/mdc3.12819 pubmed: 31538085 pmcid: 6749804

Chaudhuri KR et al (2006) Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol 5(3):235–245

doi: 10.1016/S1474-4422(06)70373-8 pubmed: 16488379

Chaudhuri KR et al (2007) The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: results from an international pilot study. Mov Disord 22(13):1901–1911

doi: 10.1002/mds.21596 pubmed: 17674410

Chaudhuri JR, Rukmini MK, Bandaru VS (2021) Prevalence of non-motor symptoms in parkinson’s disease: a study from South India. Turk J Neurol 27:52–57

doi: 10.4274/tnd.2021.52993

Deuschl G et al (2006) A randomized trial of deep-brain stimulation for Parkinson’s disease. N Engl J Med 355(9):896–908

doi: 10.1056/NEJMoa060281 pubmed: 16943402

Fernandes M et al (2021) Frequency of non-motor symptoms in Parkinson’s patients with motor fluctuations. Front Neurol 12:678373

doi: 10.3389/fneur.2021.678373 pubmed: 34267721 pmcid: 8276257

Goetz CG et al (2008) Movement disorder society-sponsored revision of the unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23(15):2129–2170

doi: 10.1002/mds.22340 pubmed: 19025984

Gronostay A et al (2023) Stratifying quality of life outcome in subthalamic stimulation for Parkinson’s disease. J Neurol Neurosurg Psychiatry. https://doi.org/10.1136/jnnp-2023-332272

doi: 10.1136/jnnp-2023-332272 pubmed: 38124227

Hely MA et al (2008) The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov Disord 23(6):837–844

doi: 10.1002/mds.21956 pubmed: 18307261

Hogg E et al (2017) Deep brain stimulation and nonmotor symptoms. Int Rev Neurobiol 134:1045–1089

doi: 10.1016/bs.irn.2017.05.022 pubmed: 28805564

Jafari N et al (2016) MDS-UPDRS to assess non-motor symptoms after STN DBS for Parkinson’s disease. Int J Neurosci 126(1):25–29

doi: 10.3109/00207454.2015.1065257 pubmed: 26134878

Jenkinson C et al (1997) The Parkinson’s Disease Questionnaire (PDQ-39): development and validation of a Parkinson’s disease summary index score. Age Ageing 26(5):353–357

doi: 10.1093/ageing/26.5.353 pubmed: 9351479

Khoo TK et al (2013) The spectrum of nonmotor symptoms in early Parkinson disease. Neurology 80(3):276–281

doi: 10.1212/WNL.0b013e31827deb74 pubmed: 23319473 pmcid: 3589180

Kim HJ et al (2015) Nonmotor symptoms and subthalamic deep brain stimulation in Parkinson’s disease. J Mov Disord 8(2):83–91

doi: 10.14802/jmd.15010 pubmed: 26090080 pmcid: 4460544

Krack P et al (2003) Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 349(20):1925–1934

doi: 10.1056/NEJMoa035275 pubmed: 14614167

Kurtis MM et al (2017) The effect of deep brain stimulation on the non-motor symptoms of Parkinson’s disease: a critical review of the current evidence. NPJ Parkinsons Dis 3:16024

doi: 10.1038/npjparkd.2016.24 pubmed: 28725706 pmcid: 5516616

Lee JY et al (2014) Extrastriatal dopaminergic changes in Parkinson’s disease patients with impulse control disorders. J Neurol Neurosurg Psychiatry 85(1):23–30

doi: 10.1136/jnnp-2013-305549 pubmed: 24023269

Leentjens AF et al (2011) Anxiety rating scales in Parkinson’s disease: a validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale. Mov Disord 26(3):407–415

doi: 10.1002/mds.23184 pubmed: 21384425

Lieberman A (2006) Depression in Parkinson’s disease—a review. Acta Neurol Scand 113(1):1–8

doi: 10.1111/j.1600-0404.2006.00536.x pubmed: 16367891

Martinez-Martin P et al (2011) The impact of non-motor symptoms on health-related quality of life of patients with Parkinson’s disease. Mov Disord 26(3):399–406

doi: 10.1002/mds.23462 pubmed: 21264941

Nazzaro JM et al (2011) The impact of bilateral subthalamic stimulation on non-motor symptoms of Parkinson’s disease. Parkinsonism Relat Disord 17(8):606–609

doi: 10.1016/j.parkreldis.2011.05.009 pubmed: 21669545

Noyce AJ et al (2012) Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol 72(6):893–901

doi: 10.1002/ana.23687 pubmed: 23071076 pmcid: 3556649

Obeso JA et al (2008) The basal ganglia in Parkinson’s disease: current concepts and unexplained observations. Ann Neurol 64(Suppl 2):S30-46

pubmed: 19127584

Quinn NP et al (1986) Painful Parkinson’s disease. Lancet 1(8494):1366–1369

doi: 10.1016/S0140-6736(86)91674-0 pubmed: 2872480

Reich MM, Chaudhuri KR, Ashkan K, Hulse N, Costello A, Moriarty J (2011) Changes in the non-motor symptom scale in Parkinson’s disease after deep brain stimulation. Basal Ganglia 1(3):131–133

doi: 10.1016/j.baga.2011.08.002

Rodriguez-Oroz MC et al (2005) Bilateral deep brain stimulation in Parkinson’s disease: a multicentre study with 4 years follow-up. Brain 128(Pt 10):2240–2249

doi: 10.1093/brain/awh571 pubmed: 15975946

Rukmini Mridula K et al (2015) Comparison of frequencies of non motor symptoms in Indian Parkinson’s disease patients on medical management versus deep brain stimulation: a case-control study. Iran J Neurol 14(2):86–93

pubmed: 26056553 pmcid: 4449399

Sakakibara R et al (2003) Colonic transit time and rectoanal videomanometry in Parkinson’s disease. J Neurol Neurosurg Psychiatry 74(2):268–272

doi: 10.1136/jnnp.74.2.268 pubmed: 12531969 pmcid: 1738286

Schrag A et al (2000) How does Parkinson’s disease affect quality of life? A comparison with quality of life in the general population. Mov Disord 15(6):1112–1118

doi: 10.1002/1531-8257(200011)15:6<1112::AID-MDS1008>3.0.CO;2-A pubmed: 11104193

Schrag A et al (2007) Depression rating scales in Parkinson’s disease: critique and recommendations. Mov Disord 22(8):1077–1092

doi: 10.1002/mds.21333 pubmed: 17394234 pmcid: 2040268

Su ZH et al (2023) Deep brain stimulation and levodopa affect gait variability in Parkinson disease differently. Neuromodulation 26(2):382–393

doi: 10.1016/j.neurom.2022.04.035 pubmed: 35562261

Takeshita S et al (2005) Effect of subthalamic stimulation on mood state in Parkinson’s disease: evaluation of previous facts and problems. Neurosurg Rev 28(3):179–186 (Discussion 187)

doi: 10.1007/s10143-005-0387-4 pubmed: 15827764

Tomlinson CL et al (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25(15):2649–2653

doi: 10.1002/mds.23429 pubmed: 21069833

Weiss D et al (2021) Changing gears—DBS for dopaminergic desensitization in Parkinson’s disease? Ann Neurol 90(5):699–710

doi: 10.1002/ana.26164 pubmed: 34235776

Witjas T et al (2007) Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson’s disease. Mov Disord 22(12):1729–1734

doi: 10.1002/mds.21602 pubmed: 17557355

Witt K et al (2008) Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson’s disease: a randomised, multicentre study. Lancet Neurol 7(7):605–614

doi: 10.1016/S1474-4422(08)70114-5 pubmed: 18538636

Zibetti M et al (2007) Motor and nonmotor symptom follow-up in Parkinsonian patients after deep brain stimulation of the subthalamic nucleus. Eur Neurol 58(4):218–223

doi: 10.1159/000107943 pubmed: 17823535